{"id":"NCT03282240","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants â‰¥65 Years in the US","officialTitle":"Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Participants Aged 65 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-08","primaryCompletion":"2017-11-02","completion":"2018-04-19","firstPosted":"2017-09-13","resultsPosted":"2019-12-17","lastUpdate":"2022-04-07"},"enrollment":2670,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"QIV-HD","otherNames":["High-dose quadrivalent influenza vaccine"]},{"type":"BIOLOGICAL","name":"Licensed TIV-HD1","otherNames":["High-dose trivalent influenza vaccine"]},{"type":"BIOLOGICAL","name":"Investigational TIV-HD2","otherNames":["High-dose trivalent influenza vaccine (alternate B strain)"]}],"arms":[{"label":"QIV-HD","type":"EXPERIMENTAL"},{"label":"TIV-HD1 (Licensed TIV-HD1)","type":"ACTIVE_COMPARATOR"},{"label":"TIV-HD2 (Investigational TIV-HD2)","type":"ACTIVE_COMPARATOR"}],"summary":"This randomized, modified double-blind, active-controlled, multi-center trial assessed the safety and immunogenicity of the high-dose quadrivalent influenza vaccine (QIV-HD) compared to either the licensed or investigational high-dose trivalent influenza vaccine (TIV-HD) in adults.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) of Influenza Antibodies Following Vaccination With Either a High-Dose Quadrivalent Influenza Vaccine or High-Dose Trivalent Influenza Vaccine","timeFrame":"Day 28 post-vaccination","effectByArm":[{"arm":"High-Dose Quadrivalent Influenza Vaccine (QIV-HD)","deltaMin":312,"sd":null},{"arm":"High-Dose Trivalent Influenza Vaccines (Licensed TIV-HD1)","deltaMin":387,"sd":null},{"arm":"High-Dose Trivalent Influenza Vaccine(Investigational TIV-HD2)","deltaMin":362,"sd":null},{"arm":"High-Dose Trivalent Influenza Vaccines Pooled (TIV-HDs Pooled)","deltaMin":374,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG003","p":null},{"comp":"OG000 vs OG003","p":null}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":36,"countries":["United States"]},"refs":{"pmids":["31431411"],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":80,"n":1777},"commonTop":["Injection Site Pain","Myalgia","Headache","Malaise","Injection Site Erythema"]}}